WTX212A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for WTX212A, covering 2025-01-16 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors [Phase 1]